Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via Google Scholar



	Articles by Davidson, M.
	Articles by Davis, K. L.
	Search for Related Content



	PubMed Citation
	Articles by Davidson, M.
	Articles by Davis, K. L.

Am J Psychiatry 1988; 145:1007-1009
Copyright © 1988 by American Psychiatric Association

REGULAR ARTICLES

Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects

M Davidson, BM Davis, L Bastiaens, J Macaluso, M Aryan, T Ryan and KL Davis
Department of Psychiatry, Bronx VA Medical Center, NY 10468.

The authors found that growth hormone (GH) response to edrophonium was no different in 12 Alzheimer's disease patients than in eight healthy elderly subjects. Previously reported differences could be due to differences in gender or baseline GH concentrations between patients and control subjects.

Get information about faster international access.